PAPER Moghimi SM
SEARCH RESULTS
330907 RESULTS
PAPER Engmann O, Hortobágyi T, Thompson AJ, Guadagno J, Troakes C, Soriano S, Al-Sarraj S, Kim Y, Giese KP
Cyclin-dependent kinase 5 activator p25 is generated during memory formation and is reduced at an early stage in Alzheimer's disease.
Biol Psychiatry. 2011 Jul 15;70(2):159-68. PubMed: 21616478PAPER Hudson AE, Hemmings HC
Are anaesthetics toxic to the brain?
Br J Anaesth. 2011 Jul;107(1):30-7. PubMed: 21616941PAPER Carter SF, Caine D, Burns A, Herholz K, Lambon Ralph MA
Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease.
Int J Geriatr Psychiatry. 2011 May 25; PubMed: 21618285PAPER Echávarri C, Caballero MC, Aramendía A, García-Bragado F, Tuñón T
Multiprotein deposits in neurodegenerative disorders: our experience in the tissue brain bank of Navarra.
Anat Rec (Hoboken). 2011 Jul;294(7):1191-7. PubMed: 21618706PAPER Rosen BR, Napadow V
Quantitative markers for neuropsychiatric disease: give it a rest.
Radiology. 2011 Apr;259(1):17-9. PubMed: 21436093PAPER Kavanagh S, Gaudig M, Van Baelen B, Adami M, Delgado A, Guzman C, Jedenius E, Schäuble B
Galantamine and behavior in Alzheimer disease: analysis of four trials.
Acta Neurol Scand. 2011 Nov;124(5):302-8. PubMed: 21615354PAPER McGough EL, Kelly VE, Logsdon RG, McCurry SM, Cochrane BB, Engel JM, Teri L
Associations between physical performance and executive function in older adults with mild cognitive impairment: gait speed and the timed "up & go" test.
Phys Ther. 2011 Aug;91(8):1198-207. PubMed: 21616934PAPER Abeti R, Abramov AY, Duchen MR
Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death.
Brain. 2011 Jun;134(Pt 6):1658-72. PubMed: 21616968PAPER Chen CS, Ouyang P, Yeh YC, Lai CL, Liu CK, Yen CF, Ko CH, Yen JY, Liu GC, Juo SH
Apolipoprotein E Polymorphism and Behavioral and Psychological Symptoms of Dementia in Patients With Alzheimer Disease.
Alzheimer Dis Assoc Disord. 2011 May 25; PubMed: 21617520PAPER Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, Dickson DW
Neuropathological background of phenotypical variability in frontotemporal dementia.
Acta Neuropathol. 2011 Aug;122(2):137-53. PubMed: 21614463PAPER Chen-Plotkin AS, Martinez-Lage M, Sleiman PM, Hu W, Greene R, Wood EM, Bing S, Grossman M, Schellenberg GD, Hatanpaa KJ, Weiner MF, White CL, Brooks WS, Halliday GM, Kril JJ, Gearing M, Beach TG, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Pickering-Brown SM, Snowden J, van Swieten JC, Heutink P, Seelaar H, Murrell JR, Ghetti B, Spina S, Grafman J, Kaye JA, Woltjer RL, Mesulam M, Bigio E, Lladó A, Miller BL, Alzualde A, Moreno F, Rohrer JD, Mackenzie IR, Feldman HH, Hamilton RL, Cruts M, Engelborghs S, De Deyn PP, Van Broeckhoven C, Bird TD, Cairns NJ, Goate A, Frosch MP, Riederer PF, Bogdanovic N, Lee VM, Trojanowski JQ, Van Deerlin VM
Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration.
Arch Neurol. 2011 Apr;68(4):488-97. PubMed: 21482928PAPER van der Zee J, Van Broeckhoven C
TMEM106B a novel risk factor for frontotemporal lobar degeneration.
J Mol Neurosci. 2011 Nov;45(3):516-21. PubMed: 21614538PAPER Oberlaender M, Boudewijns ZS, Kleele T, Mansvelder HD, Sakmann B, de Kock CP
Three-dimensional axon morphologies of individual layer 5 neurons indicate cell type-specific intracortical pathways for whisker motion and touch.
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4188-93. PubMed: 21368112PAPER Nielsen JA, Chambers MA, Romm E, Lee LY, Berndt JA, Hudson LD
Mouse transmembrane BAX inhibitor motif 3 (Tmbim3) encodes a 38 kDa transmembrane protein expressed in the central nervous system.
Mol Cell Biochem. 2011 Nov;357(1-2):73-81. PubMed: 21614515Current Filters
No filters selected